Sunnova Announces Second Quarter 2024 Earnings Release Date and Conference Call
Sunnova Announces Second Quarter 2024 Earnings Release Date and Conference Call
Sunnova Energy International Inc. ("Sunnova") (NYSE: NOVA), a leading adaptive energy services company, announced today it will release its second quarter 2024 results after the markets close on July 31, 2024, to be followed by a conference call to discuss the results at 8:00 a.m. Eastern Time on August 1, 2024.
The conference call can be accessed live over the phone by dialing 833-470-1428 or 404-975-4839. The access code for the live call is 049171.
Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of Sunnova’s website at https://investors.sunnova.com.
About Sunnova
Sunnova Energy International Inc. (NYSE: NOVA) is an industry-leading adaptive energy services company focused on making clean energy more accessible, reliable, and affordable for homeowners and businesses. Through its adaptive energy platform, Sunnova provides a better energy service at a better price to deliver its mission of powering energy independence. For more information, visit https://www.sunnova.com.
Sunnova Investor Contact:
Rodney McMahan
IR@sunnova.com
713-997-2444
Sunnova Media Contact:
Ryan Bechtold
Ryan.Bechtold@sunnova.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20240710190343/en/
-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks